31 Dec 2025 | 07:00
Total Voting Rights
/**/
RNS Number : 0434N GCP Asset Backed Income Fund Ltd 31 December 2025
GCP Asset Backed Income Fund Limited
("GABI" or the "Company")
LEI: 213800FBBZCQMP73A815
Total Voting Rights
31 December 2025
The Company, which invests in asset backed loans, would like to notify the market of the following in conformity with the FCA's Disclosure Guidance and Transparency Rules:
As at 31 December 2025, the Company has in issue 171,903,104 ordinary shares of which none are held in treasury.
For reporting purposes under the FCA's Disclosure Guidance and Transparency Rules the market should use the figure of 171,903,104 voting rights when determining if they are required to notify their interest in, or a change to their interest in the Company.
For further information, please contact:
GCP Asset Backed Income Fund Limited
Alex Ohlsson, Chairman
+44 (0)15 3482 2251
Barclays Bank PLC
Dion Di Miceli
Stuart Muress
James Atkinson
+44 (0)20 7623 2323
Gravis Capital Management Limited
Philip Kent
Luther Ward-Faint
Cameron Gardener
+44 (0)20 3405 8500
Burson Buchanan
Helen Tarbet
Henry Wilson
Nick Croysdill
+44 (0)20 7466 5000
Notes to the Editor
About GABI
GCP Asset Backed Income Fund Limited is a closed ended investment company. Its shares are traded on the Main Market of the London Stock Exchange. Its investment objective is to undertake a managed wind-down of the Company and realise all existing assets in the Company's portfolio in an orderly manner.
The Company's portfolio comprises a diversified portfolio of predominantly UK based asset backed loans which are secured against contracted, predictable medium to long term cash flows and/or physical assets.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END TVREANAEDEASFEA